Comprehensive pleural fluid analysis should be performed first, including specific biomarkers such as adenosine deaminase levels, lactate dehydrogenase, cytological examination, and tumor marker assessment, particularly for conditions such as lung adenocarcinoma and mesothelioma. The gene discussed is ADA; the disease is mesothelioma.